Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,946 | 9 | 98.5% |
| Travel and Lodging | $150.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $3,816 | 3 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $3,530 | 2 | $0 (2017) |
| Vertex Pharmaceuticals Incorporated | $1,100 | 3 | $0 (2022) |
| Shionogi Inc | $900.00 | 1 | $0 (2022) |
| CIPLA USA INC. | $750.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,250 | 2 | Shionogi Inc ($900.00) |
| 2021 | $350.00 | 1 | Vertex Pharmaceuticals Incorporated ($350.00) |
| 2020 | $2,493 | 2 | Janssen Research & Development, LLC ($2,493) |
| 2019 | $2,073 | 2 | Janssen Research & Development, LLC ($1,323) |
| 2018 | $400.00 | 1 | Vertex Pharmaceuticals Incorporated ($400.00) |
| 2017 | $3,530 | 2 | Merck Sharp & Dohme Corporation ($3,530) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2022 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 05/19/2022 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 07/14/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 12/11/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $893.25 | General |
| 11/11/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 09/30/2019 | CIPLA USA INC. | 4 (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2019 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,323.00 | General |
| 03/21/2018 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 02/20/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,380.00 | General |
| 02/20/2017 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
About Dr. John Lipuma, MD
Dr. John Lipuma, MD is a Pediatrics healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700892981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lipuma, MD has received a total of $10,096 in payments from pharmaceutical and medical device companies, with $1,250 received in 2022. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($9,946).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Infectious Diseases
- Location Ann Arbor, MI
- Active Since 07/31/2006
- Last Updated 11/15/2019
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1700892981
Products in Payments
- Fetroja (Drug) $900.00
- 4 (Drug) $750.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Ann Arbor
Jordan Shavit, Md, MD
Pediatrics — Payments: $209,597
Dr. Jeffrey Zampi, Md, MD
Pediatrics — Payments: $188,895
Steven Donn, Md, MD
Pediatrics — Payments: $113,934
Andrew Campbell, Md, MD
Pediatrics — Payments: $96,431
Maysa Hamade, M.d, M.D
Pediatrics — Payments: $90,101
David Svilar
Pediatrics — Payments: $66,000